Finance

Lists
TRVI:NASDAQ
Trevi Therapeutics Inc
US$ १३.०८
-०.४६%
(-०.०६०) 1D
अक्टोबर ८, १४:४२:१० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRVI...
Open
US$ १२.९६
High
US$ १३.२८
Low
US$ १२.३२
Mkt. cap
१.८६ अरब
Avg. vol.
१९.०४ लाख
Volume
२४.४२ लाख
52-wk high
US$ २०.१५
52-wk low
US$ ९.२९
EPS
-US$ ०.३४
Beta
०.९८
Shares outstanding
१४.२५ करोड
No. of employees
३४
Open
US$ १२.९६
High
US$ १३.२८
Low
US$ १२.३२
Mkt. cap
१.८६ अरब
Avg. vol.
१९.०४ लाख
Volume
२४.४२ लाख
52-wk high
US$ २०.१५
52-wk low
US$ ९.२९
EPS
-US$ ०.३४
Beta
०.९८
Shares outstanding
१४.२५ करोड
No. of employees
३४
News stories
From web sources and news partners
About Trevi Therapeutics Inc
CEO-
Employees३४
Founded२०११
Headquartersन्यू हेवन, कनेक्टिकट, संयुक्त राज्य अमेरिका
Sector-
Websitetrevitherapeutics.com
Analyst ratings
Based on 10 analysts giving stock ratings to TRVI in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for TRVI in the last 3 months.
Highest
Current US$ १३.०८
US$ ४०.०० (+२०५.८१%)
Average
US$ २९.०० (+१२१.७१%)
Lowest
US$ २३.०० (+७५.८४%)
Analyst
Recommendation
Action
Price target
Projected
Date
Conor MacKay
BMO Capital
Buy
Maintained
US$ ३६.००
+१७५.२%
10/06/2026
Brandon Folkes
H.C. Wainwright
Buy
Maintained
US$ २४.००
+८३.५%
09/21/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
US$ २८.००
+११४.१%
08/13/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
US$ २३.००
+७५.८%
08/10/2026
Serge Belanger
Needham
Buy
Maintained
US$ २३.००
+७५.८%
08/07/2026
Ryan Deschner
Raymond James
Buy
Maintained
US$ ४०.००
+२०५.८%
08/07/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
US$ ३१.००
+१३७%
08/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
US$ ३०.००
+१२९.४%
08/06/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
US$ २५.००
+९१.१%
08/07/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
US$ ३०.००
+१२९.४%
08/07/2026
Evan Seigerman
BMO Capital
Buy
Initiated
US$ ३६.००
+१७५.२%
07/21/2026
Unknown Analyst
BMO Capital
Buy
Initiated
US$ ३६.००
+१७५.२%
07/20/2026
William Wood
B. Riley Securities
Buy
Reiterated
US$ ३१.००
+१३७%
07/17/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
US$ २९.००
+१२१.७%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.०१ करोड
६१.९३ लाख
९९.४१ लाख
१.५२ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३८.३१ लाख
४०.२७ लाख
४९.७१ लाख
५३.५७ लाख
Operating expense
१.३९ करोड
१.०२ करोड
१.४९ करोड
२.०५ करोड
Total operating expenses
१.३९ करोड
१.०२ करोड
१.४९ करोड
२.०५ करोड
Operating income
-१.३९ करोड
-१.०२ करोड
-१.४९ करोड
-२.०५ करोड
Other non operating income
-२.०० हजार
-१५.०० हजार
-
-
EBT including unusual items
-१.१८ करोड
-८३.३२ लाख
-१.३२ करोड
-१.७८ करोड
EBT excluding unusual items
-१.१८ करोड
-८३.३२ लाख
-१.३२ करोड
-१.७८ करोड
Income tax expense
-१५.०० हजार
-१६.०० हजार
-२०.०० हजार
-१९.०० हजार
Effective tax rate
०.१३%
०.१९%
०.१५%
०.११%
Other operating expenses
-
-
-
-
Net income
-१.१८ करोड
-८३.१६ लाख
-१.३२ करोड
-१.७८ करोड
Net profit margin
-
-
-
-
Earnings per share
-०.०८
-०.०६
-०.०९
-०.११
Interest and investment income
२१.०१ लाख
१९.०३ लाख
१६.९६ लाख
२६.९६ लाख
Interest expense
-
-
-
-
Net interest expenses
२१.०१ लाख
१९.०३ लाख
१६.९६ लाख
२६.९६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.३९ करोड
-१.०२ करोड
-१.४९ करोड
-२.०५ करोड
Gain or loss from assets sale
-
७.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू